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DOI 10.1016/j.cell.2008.04.026The synthesis of ribosomal RNA (rRNA) is carefully tuned to match nutritional conditions. In this 
issue, Murayama et al. (2008) describe a mechanism that couples the energy status of the cell 
to heterochromatin formation and silencing of rRNA genes. They show that an altered NAD+/
NADH ratio in response to glucose starvation regulates the silencing activity of eNoSC, a complex 
consisting of the NAD+-dependent histone deacetylase SIRT1, the histone methyltransferase 
SUV39H1, and a new protein called nucleomethylin (NML). These results suggest a mechanism 
that links cell physiology to rDNA silencing, which in turn is a prerequisite for nucleolar integrity 
and cell survival.The rate of cell growth and proliferation is proportional to 
the rate of protein synthesis, which is in turn tightly linked to 
ribosome biogenesis. The synthesis of rRNA, the rate-lim-
iting step in ribosome synthesis, is regulated by nutritional 
conditions. In this way, the cell strikes a balance between 
protein synthesis and the energetically costly investment of 
biosynthetic resources in manufacturing ribosomes. To keep 
up with the demand of ribosome production, eukaryotes 
maintain several hundred genes encoding rRNAs that are 
transcribed by RNA polymerase I (Pol I). Pol I transcription 
is intricately regulated to be responsive to general metabo-
lism and specific environmental challenges (for review, see 
Grummt, 2003). Transcription of rDNA can be modulated 
by varying the transcription rate per gene or by varying the Figure 1. Energy-Dependent Regulation of 
rDNA Transcription
Genes encoding ribosomal RNAs (rRNAs) ex-
ist in two functionally distinct states. At active 
genes, the promoter is unmethylated and as-
sociated with euchromatic histone modifica-
tions such as acetylated histone H3 (H3K9ac). 
The TAFI68 subunit of the promoter selectivity 
factor SL1 is also acetylated (Ac), facilitating 
its binding to the rDNA promoter and the sub-
sequent assembly of productive transcription 
initiation complexes (top left). At epigenetically 
silent genes, the chromatin remodeling complex 
NoRC, together with associated RNA (purple 
line), recruits DNA methyltransferase and his-
tone deacetylase activities to the rDNA pro-
moter, leading to deacetylation and methylation 
of H3K9, CpG DNA methylation at the promoter 
(Me), and transcriptional silencing (top right). 
Upon glucose starvation, elevation of the NAD+/
NADH ratio activates SIRT1. SIRT1 deacety-
lates the TAFI68 subunit of SL1, impairing DNA 
binding and formation of the transcription initia-
tion complex (bottom left). In addition, eNoSC, comprising SIRT1, SUV39H1, and NML, is activated leading to histone deacetylation, H3K9 methyla-
tion, and transcriptional repression (bottom right). It is not clear whether the chromatin structure of transcriptionally active genes is altered under 
low-glucose conditions.proportion of active genes. The currently accepted model 
for regulation of rDNA transcription posits two overlap-
ping mechanisms (Figure 1). For short-term regulation in 
response to growth factor signaling, nutrients, or stress, the 
transcription rate at euchromatic “active” rDNA is altered. 
In contrast, when more stable rDNA transcription is needed 
(for example, when cell-specific ratios of active versus silent 
rDNA copies are established during development), then 
rDNA transcription is regulated epigenetically, that is, by 
chromatin modifications. These two mechanisms of tran-
scriptional and epigenetic control have complicated efforts 
to identify the major pathways contributing to proliferation-
dependent and metabolism-dependent regulation of rDNA 
transcription.Cell 133, May 16, 2008 ©2008 Elsevier Inc. 577
Turning rRNA Genes on and off
Although rRNA synthesis accounts for more than 50% of cellular 
transcriptional activity, a significant fraction of the rDNA repeats 
is constitutively silent (for review, see Grummt and Pikaard, 2003). 
The technique of chromatin immunoprecipitation (ChIP) has pro-
vided valuable insights into the transcriptional activity status of 
rDNA repeats. These studies have revealed that specific histone 
modifications distinguish silent or facultative heterochromatin 
from transcriptionally permissive euchromatin. Active rRNA genes 
exhibit euchromatic features including hypomethylation of the 
promoter, acetylation of histone H3 and H4 tails, and methylation 
of histone H3 lysine 4 (H3K4). In contrast, silent rDNA repeats are 
located within chromatin regions refractory to transcription and 
bearing heterochromatic marks such as di- and trimethylation of 
histone H3 at lysine 9 (H3K9me2 and H3K9me3, respectively), at 
lysine 20 (H3K20me3), and at lysine 27 (H3K27me3) (Santoro et 
al., 2002; Yuan et al., 2007). Furthermore, the promoters of silent 
rRNA genes are hypermethylated at CpG residues. The transi-
tion of epigenetically active to silent rDNA repeats is mediated 
by NoRC (Nucleolar Remodeling Complex), a SNF2h-containing 
chromatin remodeling complex that recruits DNA methyltrans-
ferase (DNMT) and histone deacetylase activities to the promoter, 
thereby triggering heterochromatin formation and transcriptional 
silencing (Santoro and Grummt, 2005). As a consequence of 
NoRC’s interaction with DNMTs and with specific corepressors, a 
subset of rDNA repeats is silenced and specific epigenetic marks 
at the loci are propagated throughout cell division. The current 
model for the mechanism of NoRC function suggests that NoRC 
serves as a scaffold to coordinate the activities of macromolecu-
lar complexes that modify histones, methylate DNA, and establish 
a “closed” heterochromatin structure.
Studies in the budding yeast Saccharomyces cerevisiae and 
the fruit fly Drosophila have demonstrated that rDNA silenc-
ing plays an important role in genome stability through the 
suppression of nonhomologous recombination pathways. 
Loss of silencing at rDNA loci correlates with rDNA instability, 
nucleolar disintegration, and cellular senescence (Kobayashi 
et al., 2004; Peng and Karpen, 2007). Among the key players 
that ensure rDNA stability are the NAD+-dependent histone 
deacetylase Sir2 (silent information regulator 2) in S. cerevi-
siae and the histone methyltransferase Su(var)3-9 (suppressor 
of variegation 3-9) in Drosophila. The mutation of Su(var)3-9 
results in decreased levels of H3K9me2, perturbation of nucle-
olar structure, and accumulation of extrachromosomal rDNA 
circles (Peng and Karpen, 2007). Likewise, mutations in Sir2 
lead to increased rDNA instability and shortening of replicative 
life span (Sinclair and Guarente, 1997). As Sir2 activity is regu-
lated by NAD+ levels, the finding that Sir2 plays an important 
role in rDNA stability and nucleolar activity links rRNA synthe-
sis directly to the energy prosperity of the cell.
Linking Glucose to rDNA Transcription
One of the most important environmental variables in the regu-
lation of rDNA transcription is the availability of nutrients, such 
that rRNA synthesis is tightly linked to the metabolic state of a 
cell. It has been long recognized that a given nutritional state 
gives rise to a cellular equilibrium in which the synthesis of ATP 
and GTP is balanced by their use in protein synthesis (Grummt 578 Cell 133, May 16, 2008 ©2008 Elsevier Inc.and Grummt, 1976). Accordingly, rDNA transcription is regu-
lated by intracellular ATP levels, thus providing a molecular 
explanation for the growth rate-dependent control and homeo-
static regulation of ribosome synthesis. Superimposed upon 
this regulation is the deacetylation of TAFI68, a subunit of the 
Pol I promoter selectivity factor (SL1 in humans and TIF-IB in 
mice), by the NAD+-dependent deacetylase SIRT1, which leads 
to transcriptional repression (Muth et al., 2001).
In their new study, Murayama and colleagues uncover an 
additional relationship between cellular energy status and 
rDNA transcription. They show that glucose starvation affects 
the epigenetic state of rRNA genes, suggesting a fine-tuned 
mechanism by which rDNA silencing may decrease energy 
expenditure and protect cells from energy deprivation-induced 
apoptosis. The authors identified a new protein complex, 
eNoSC (energy-dependent Nucleolar Silencing Complex), that 
changes the ratio of active to silent rRNA genes in response to 
cellular energy status. Proceeding from the observation that 
glucose starvation of cultured HeLa cells induced deacetyla-
tion of H3K9 and elevated the level of H3K9me2 at the rDNA 
promoter, the authors identified nucleomethylin (NML), a 
nucleolar protein that specifically bound to H3K9me2. NML, 
the product of the KIAA0409 gene, exhibits homology to 
methyltransferases, is localized to nucleoli, and is associated 
with chromatin throughout the rDNA repeats. Overexpres-
sion and knockdown approaches showed that manipulating 
the NML protein affected the abundance of rRNA precursors 
and the level of H3K9 methylation at rDNA promoters. Spe-
cifically, NML depletion increased pre-rRNA synthesis and 
boosted histone H3 acetylation but decreased H3K9 methyla-
tion at rDNA promoters. Conversely, overexpression of NML 
decreased H3 acetylation and increased H3K9me2 at rDNA 
promoters, resulting in the repression of pre-rRNA synthesis. 
These results suggest that NML affects rDNA transcription by 
modulating histone H3K9 methylation at the rDNA promoter, 
thereby establishing heterochromatic features and promoting 
rDNA silencing. Significantly, depletion of NML reduced the 
ability of cells to decrease pre-rRNA synthesis and to maintain 
ATP levels in response to glucose deprivation, indicating that 
NML represses rDNA transcription during limiting metabolic 
conditions. By limiting ribosome biogenesis, cellular ATP levels 
may be maintained and cells protected from apoptosis due to 
energy deprivation.
NML—An Unusual Histone-Binding Protein?
How NML links the cellular energy status with rDNA chroma-
tin remodeling in the nucleous is not fully clear, but the study 
by Murayama and colleagues offers important clues. The 
most direct link to metabolism comes from their crystal struc-
ture of the NML C-terminal region. The structure revealed a 
methyltransferase domain confirming that NML is structurally 
similar to S-adenosyl methionine (SAM)-dependent methyl-
transferases. The target of any NML-mediated enzyme activity 
remains unknown, but the SAM-binding domain of NML does 
show homology to the nucleolar protein Rrp8p of S. cerevi-
siae. In budding yeast, Rrp8p interacts with a snoRNP com-
ponent and is important for the processing of 35S pre-rRNA 
(Bousquet-Antonelli et al., 2000). Whether Rrp8p methylates 
rRNA or catalyzes methylation of nucleolar proteins that are 
involved in pre-rRNA processing is not known. What is clear, 
however, is that budding yeast lacks repressive H3K9 methyla-
tion and consistent with this, Rrp8p does not have the unusual 
H3K9me2-binding domain found in NML (which is different 
from known methyl-lysine binding modules). Future studies 
will address the molecular details of how this NML domain rich 
in both low-complexity sequence and predicted disordered 
regions specifically recognizes H3K9me2. Interestingly, Rrp8p 
interacts with histone H2A and the chromatin remodeling com-
plex Isw1, suggesting that the SAM-binding methyltransferase 
domain of Rrp8p (and possibly also of NML) is sufficient for 
recruitment to chromatin. In support of this, cells expressing a 
mutant NML protein defective in SAM binding cannot silence 
rDNA and undergo energy deprivation-induced apoptosis.
NML Teams up with SIRT1 and SUV39H1
Pathways that are regulated by feedback loops tend to share 
the general feature of having more than one entry point for 
regulation. Considering that alteration of NML protein lev-
els affects histone H3 acetylation and H3K9 methylation at 
rDNA repeats, it is perhaps not surprising that Murayama et 
al. also found a molecular connection between NML and two 
key epigenetic regulators of chromatin structure: the protein 
deacetylase SIRT1 and the heterochromatic methyltransferase 
SUV39H1. Treatment of cells with nicotinamide, an inhibitor of 
NAD+-dependent deacetylases including SIRT1, suppressed 
the NML-mediated decrease in pre-rRNA levels. Specific 
knockdown of SIRT1, the principal NAD+-dependent deacety-
lase for histones H4K16 and H3K9 and other proteins includ-
ing p53, TAFI68, MyoD, FOXO3, and PPARγ, prevented NML-
dependent transcriptional repression and increased H3K9 
acetylation. Consistent with these observations suggesting a 
specific involvement of SIRT1, overexpression of SIRT1 aug-
mented the repressive effect of NML. Moreover, the authors 
found that NML and SIRT1 interacted with SUV39H1, thereby 
linking histone H3 deacetylation to H3K9 methylation and rDNA 
silencing.
Sir2 and the mammalian homolog SIRT1 have been shown 
to deacetylate H3K9 at rDNA repeats (Liou et al., 2005). In S. 
cerevisiae, the Sir2-containing RENT complex promotes Pol I 
transcription and triggers the silencing of Pol II transcription at 
the rDNA locus. However, Sir2 itself does not have any measur-
able effect on Pol I transcription or in controlling the number of 
active rRNA encoding genes (French et al., 2003), consistent 
with the absence of H3K9 methylation in S. cerevisiae (Roguev 
et al., 2001). In contrast, deacetylation of H3K9 in higher 
eukaryotes facilitates H3K9 methylation, setting the stage for 
the action of H3K9-specific histone methyltransferases such 
as G9a, SET-DB1, and SUV39H1. Previous studies have shown 
that the methyltransferase G9a is a coactivator for Pol I tran-
scription elongation through active rDNA repeats, whereas 
SET-DB1 plays a role in NoRC-dependent heterochromatin 
formation and rDNA silencing (Yuan et al., 2007). The results of 
Murayama et al. revealed that SUV39H1 contributed to rDNA 
silencing, most likely by increasing the number of repressed 
rDNA genes, thereby restricting Pol I transcription to a smaller 
number of genes. Notably, recent work by the Reinberg labo-ratory not only demonstrated that SUV39H1 is acetylated, 
but also that SIRT1-dependent deacetylation of lysine 266 in 
the catalytic SET domain of SUV39H1 activates its enzymatic 
activity to result in increased levels of H3K9me3 (Vaquero 
et al., 2007). These findings demonstrate the involvement of 
SIRT1-dependent deacetylation in mediating SUV39H1 his-
tone methyltransferase activity and underscore the functional 
link between SUV39H1 and the deacetylase SIRT1. Consistent 
with this, Murayama et al. showed that knockdown of either 
SIRT1 or SUV39H1 resulted in decreased H3K9 methylation 
and impaired NML association with rDNA. Together, these 
observations indicate that SIRT1, SUV39H1, and NML, the 
three components of eNoSC, cooperate to silence a fraction of 
rDNA repeats. Thus, eNoSC joins a growing family of regula-
tory protein complexes containing Sir2-related deacetylases.
Integrating Fasting Signals into the Epigenetic Circuitry
Given that caloric restriction decreases the cellular ATP con-
centration and increases the NAD+/NADH ratio, the NAD+-
dependent deacetylase activity of Sir2 family members is 
enhanced when the intracellular energy supply is limiting 
(Guarente and Picard, 2005). Sir2 enzymes cooperate with 
other proteins to establish larger domains of silenced chroma-
tin. In S. cerevisiae, for example, Sir2 binds to other Sir proteins 
to form a SIR-repressive complex that is thought to spread in 
cis over chromatin to enable silencing. Similarly, eNoSC in 
mammals promotes deacetylation and methylation of H3K9 as 
well as the spread of H3K9me, which may be aided by binding 
of NML’s N-terminal domain to H3K9me2. This mechanism is 
reminiscent of the binding of heterochromatin protein 1 (HP1) 
to H3K9 methylated by SUV39H1 to facilitate spreading of 
silenced chromatin domains. It is possible that NML may carry 
out HP1-like functions in the nucleolus.
Further linking metabolism to chromatin structure, the NAD+ 
metabolite O-acetyl-ADP-ribose (AAR) induces a change in the 
structure of the S. cerevisiae SIR complex and promotes the oli-
gomerization of SIR proteins in vitro (Liou et al., 2005). It is less 
clear whether AAR has a similar corepressive role in human cells. 
However, in vitro data and structural data do identify a tantalizing 
AAR-binding function in the repressive heterochromatic histone 
variant macroH2A1.1 (Kustatscher et al., 2005). Therefore, it is 
possible that in human cells, Sir2-related enzymes, the cofactor 
NAD+, and the metabolite AAR all play a role in chromatin-medi-
ated transcriptional silencing, including at rDNA repeats.
Further research on NML and eNoSC should address the con-
nections of this complex to the activities of SIRT7, another nucleo-
lar member of the sirtuin family. SIRT7 is associated with Pol I and 
is a positive regulator of rDNA transcription (Ford et al., 2006). Like 
SIRT1, SIRT7 binds to histones, is contained in high molecular-
weight protein complexes, and is required for cell viability. Thus, 
diet-induced changes in the NAD+/NADH ratio affect both SIRT1 
and SIRT7 activity, coupling changing energy levels to rRNA syn-
thesis and ribosome production. Moreover, it will be important 
to study the mechanisms governing the nucleocytoplasmic shut-
tling of these enzymes in response to altering metabolic condi-
tions, as sirtuins and many other proteins show distinct cellular 
localizations depending on the cellular energy status. In addition, 
while it is clear that SAM binding is a prerequisite for the transcrip-Cell 133, May 16, 2008 ©2008 Elsevier Inc. 579
tional corepressor function of NML in the nucleolus, it cannot be 
excluded that instead of enzymatically using SAM as a methyl-
group donor, NML may instead act as a conformational sensor 
for SAM (or the methyltransferase product S-adenosyl homo-
cysteine). Clearly, it would be most appealing if NML assumed an 
enzymatic role for targeting RNA or protein substrates. A methyl-
transferase function for NML would be particularly exciting and 
innovative given that the budding yeast homolog Rrp8p seems to 
link the synthesis and maturation of rRNA to epigenetic changes 
in chromatin structure. Notably, all three subunits of eNoSC bind 
to metabolite cofactors and use them to carry out repressive post-
translational modifications. As cellular levels of ATP, NAD+, and 
SAM may vary depending on the physiological state of a cell, it 
stands to reason that eNoSC would be a perfect control point for 
the regulation of rDNA transcription and silencing through meta-
bolic feedback loops. This is of particular interest in the context 
of recent work on the mutual interdependency between distinct 
metabolite-driven posttranslational modifications (Vaquero et al., 
2007). Although this is not a simple “I control you, you control me” 
scenario, SIRT1 and SUV39H1 (and many other enzymatically 
coupled systems) may profit from this type of interdependency. 
Rather than following strict binary logic, the mutual dependence 
on distinct metabolites may allow these critical epigenetic regu-
lators to gain more sophisticated and physiologically responsive 
modes of regulation.
How Metabolite Players Balance the Gene Expression 
Checkbook
There appears to be a resurgence of interest in the “old” field 
of metabolism. Not only do modern mass spectrometry meth-
ods allow us to gather more comprehensive quantitative data 
regarding metabolism such that we can begin to model organis-
mal “metabolomics,” but also many “old” metabolic players are 
re-emerging in new guises. This is particularly the case in the 
field of gene expression (for review, see Ladurner, 2006). There 
will likely be more surprises in store, possibly involving the many 
metabolic enzymes that primarily function in the cytoplasm but 
can shuttle into the nucleus under certain metabolic conditions.
What new functions might metabolic enzymes have co-opted 
to control gene expression? One could borrow an important 
concept from the study of metabolic pathways, that is, the well 
known model of so-called “futile cycles” in which there is a 
very rapid change in metabolic flux upon a small change in a 
metabolic parameter. In other words, wasting a small amount of 
energy (NAD+, SAM, or acetyl-CoA) in the right place to dynami-
cally regulate activating and repressive histone modifications 
may be the optimal way to keep track of the overall level of cel-
lular energy expenditure. In the case of rDNA transcription, the 
biogenesis of functional ribosomes unquestionably represents a 
large commitment in energy expenditure for the cell. Therefore it 
may not be so surprising that NML, SIRT1, and SUV39H1 coop-
erate with other epigenetic modifiers, such as the methyltrans-
ferase G9a, to tightly regulate the level of rRNA synthesis and 
that all of these proteins, directly or indirectly, are under sepa-
rate but interconnected forms of metabolic control. Together, 
these proteins interact with endogenous metabolites to modify 
targets and to establish an activity profile for overall rDNA tran-
scription that ensures the synthesis of the optimal number of 580 Cell 133, May 16, 2008 ©2008 Elsevier Inc.functional ribosomes. In doing so, these proteins may help to 
achieve a kind of homeostatic control, enabling the cell to avoid 
precipitous losses in ATP and NADH and hence promoting cell 
viability and the long-term survival of the organism.
If we may use a metaphor to highlight one key concept of 
the Murayama et al. paper, we need to look no further than 
the current woes of the financial markets. Any prudent investor 
would skirt “irrational exuberance” (to quote Alan Greenspan, 
the former chairman of the United States Federal Reserve) and 
instead would invest a good deal of energy in making well-in-
formed decisions that balance the investment portfolio for the 
short-term and the long-term. Similarly, the eNoSC complex, 
NoRC, CSB, G9a, and other regulators of rDNA transcription, 
remind us that like any other budget or investment manager, a 
cell needs to be able to sense and clearly assess its metabolic 
state. In this way, a cell can plan its commitment to significant 
energy investments, such as the synthesis of ribosomes, and 
can decide whether to throttle back on rDNA transcription, the 
key regulatory step in ribosome biogenesis.
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